000 01462 a2200469 4500
005 20250516153258.0
264 0 _c20140318
008 201403s 0 0 eng d
022 _a1460-2083
024 7 _a10.1093/hmg/ddt252
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRavenscroft, Gianina
245 0 0 _aCardiac α-actin over-expression therapy in dominant ACTA1 disease.
_h[electronic resource]
260 _bHuman molecular genetics
_cOct 2013
300 _a3987-97 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActins
_xgenetics
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aGenes, Recessive
650 0 4 _aGenetic Therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMuscle, Skeletal
_xmetabolism
650 0 4 _aMuscular Diseases
_xgenetics
650 0 4 _aMutation
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aPhenotype
700 1 _aMcNamara, Elyshia
700 1 _aGriffiths, Lisa M
700 1 _aPapadimitriou, John M
700 1 _aHardeman, Edna C
700 1 _aBakker, Anthony J
700 1 _aDavies, Kay E
700 1 _aLaing, Nigel G
700 1 _aNowak, Kristen J
773 0 _tHuman molecular genetics
_gvol. 22
_gno. 19
_gp. 3987-97
856 4 0 _uhttps://doi.org/10.1093/hmg/ddt252
_zAvailable from publisher's website
999 _c22807844
_d22807844